Free Trial

Axon Enterprise (AXON) Financials

Axon Enterprise logo
$559.39 +428.22 (+326.46%)
As of 04/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Axon Enterprise

Annual Income Statements for Axon Enterprise

This table shows Axon Enterprise's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
20 17 5.21 546 0.88 -1.72 -60 147 176 377
Consolidated Net Income / (Loss)
20 17 5.21 29 0.88 -1.72 -60 147 176 377
Net Income / (Loss) Continuing Operations
20 17 5.21 546 0.88 -1.72 -60 147 176 377
Total Pre-Tax Income
35 31 16 28 2.07 -6.29 -141 196 157 382
Total Operating Income
35 32 13 25 -6.39 -14 -168 93 157 59
Total Gross Profit
129 171 207 517 307 416 541 726 955 1,241
Total Revenue
198 268 344 840 531 681 863 1,187 1,561 2,083
Operating Revenue
198 268 344 840 531 681 863 1,187 1,561 2,083
Total Cost of Revenue
69 98 137 323 224 265 322 461 605 841
Operating Cost of Revenue
69 98 137 323 224 265 322 461 605 841
Total Operating Expenses
93 139 194 -25 314 430 709 633 799 1,183
Selling, General & Admin Expense
70 108 139 157 213 307 515 399 495 741
Research & Development Expense
24 31 55 77 101 123 194 234 304 442
Total Other Income / (Expense), net
0.03 -0.35 2.74 3.26 8.46 7.86 27 103 0.21 323
Interest & Investment Income
0.03 -0.35 2.74 3.26 8.46 7.86 1.48 4.29 42 37
Other Income / (Expense), net
- - - - - - 25 99 -42 286
Income Tax Expense
15 14 11 -1.10 1.19 -4.57 -81 49 -19 4.47
Basic Earnings per Share
$0.37 $0.33 $0.10 $0.52 $0.01 ($0.03) ($0.91) $2.07 $2.37 $4.98
Weighted Average Basic Shares Outstanding
53.55M 52.67M 52.73M 56.39M 59.19M 61.78M 66.19M 71.09M 74.20M 75.75M
Diluted Earnings per Share
$0.36 $0.32 $0.10 $0.50 $0.01 ($0.03) ($0.91) $2.03 $2.33 $4.80
Weighted Average Diluted Shares Outstanding
54.64M 53.54M 53.90M 57.92M 60.02M 61.78M 66.19M 72.53M 75.46M 78.56M
Weighted Average Basic & Diluted Shares Outstanding
53.90M 52.40M 52.10M 58.83M 59.53M 63.78M 70.93M 72.86M 75.30M 76.62M

Quarterly Income Statements for Axon Enterprise

This table shows Axon Enterprise's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
12 29 45 12 61 57 133 41 67 136
Consolidated Net Income / (Loss)
12 29 45 12 61 57 133 41 67 136
Net Income / (Loss) Continuing Operations
12 29 45 12 61 57 133 41 67 136
Total Pre-Tax Income
21 34 42 -12 72 56 166 51 80 86
Total Operating Income
32 22 17 40 57 43 16 33 24 -15
Total Gross Profit
193 203 204 232 257 263 260 304 331 347
Total Revenue
312 333 343 375 413 430 461 504 544 573
Operating Revenue
312 333 343 375 413 430 461 504 544 573
Total Cost of Revenue
118 130 139 142 157 167 201 200 214 227
Operating Cost of Revenue
118 130 139 142 157 167 201 200 214 227
Total Operating Expenses
161 181 187 192 199 220 244 271 307 362
Selling, General & Admin Expense
102 112 117 120 122 136 153 169 192 227
Research & Development Expense
59 69 71 72 77 84 91 101 114 135
Total Other Income / (Expense), net
-11 12 25 -52 14 13 149 18 55 100
Interest & Investment Income
-11 -87 9.67 9.66 10 12 10 9.78 11 5.46
Other Income / (Expense), net
- - 16 -62 3.85 0.67 139 7.93 45 95
Income Tax Expense
8.73 5.48 -3.26 -25 10 -1.36 33 9.79 13 -50
Basic Earnings per Share
$0.17 $0.41 $0.62 $0.17 $0.82 $0.76 $1.77 $0.54 $0.89 $1.78
Weighted Average Basic Shares Outstanding
71.11M 71.09M 72.64M 74.22M 74.83M 74.20M 75.36M 75.51M 75.70M 75.75M
Diluted Earnings per Share
$0.17 $0.39 $0.61 $0.16 $0.81 $0.75 $1.73 $0.53 $0.86 $1.68
Weighted Average Diluted Shares Outstanding
72.53M 72.53M 73.88M 75.78M 75.95M 75.46M 77.13M 77.55M 78.08M 78.56M
Weighted Average Basic & Diluted Shares Outstanding
71.17M 72.86M 73.89M 74.76M 74.93M 75.30M 75.47M 75.57M 76.25M 76.62M

Annual Cash Flow Statements for Axon Enterprise

This table details how cash moves in and out of Axon Enterprise's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
11 -16 34 273 -179 -17 201 -0.89 245 -134
Net Cash From Operating Activities
46 21 18 64 66 38 124 235 189 408
Net Cash From Continuing Operating Activities
46 21 18 64 66 38 124 235 189 408
Net Income / (Loss) Continuing Operations
20 17 5.21 29 0.88 -1.72 -60 147 176 377
Consolidated Net Income / (Loss)
20 17 5.21 29 0.88 -1.72 -60 147 176 377
Depreciation Expense
3.29 3.66 8.04 11 11 12 19 23 19 48
Non-Cash Adjustments To Reconcile Net Income
0.38 9.10 17 25 86 142 285 24 191 141
Changes in Operating Assets and Liabilities, net
21 -10 -12 -1.42 -33 -117 -125 41 -197 -158
Net Cash From Investing Activities
-36 -3.05 19 -9.86 -241 -357 253 -831 12 -491
Net Cash From Continuing Investing Activities
-36 -3.05 19 -9.86 -241 -357 253 -831 12 -491
Purchase of Property, Plant & Equipment
-6.00 -4.96 -10 -11 -16 -73 -50 -56 -60 -79
Acquisitions
-12 -7.00 -12 -5.55 -0.40 -0.24 -23 -2.10 -21 -622
Purchase of Investments
-62 -56 -20 -4.33 -354 -664 -408 -845 -564 -793
Sale and/or Maturity of Investments
44 65 61 11 130 380 733 72 657 1,003
Other Investing Activities, net
- - - 0.00 - - - -0.02 -0.54 0.05
Net Cash From Financing Activities
0.60 -35 -3.82 219 -3.94 299 -174 598 41 -45
Net Cash From Continuing Financing Activities
0.60 -35 -3.82 219 -3.94 299 -174 598 41 -45
Repayment of Debt
-0.08 - - - - - - 0.00 0.00 -1.84
Issuance of Debt
- - - - - 0.00 0.00 674 0.00 0.00
Issuance of Common Equity
- 0.00 0.00 234 0.00 0.00 0.00 124 0.00 0.00
Other Financing Activities, net
8.24 -0.81 -3.82 -15 -3.94 299 -174 -200 41 -44
Effect of Exchange Rate Changes
0.12 0.91 - - 0.33 1.98 -1.98 -3.38 2.07 -6.21
Cash Interest Paid
- - - - - - - 0.00 3.51 3.45
Cash Income Taxes Paid
- - - - - - - 11 64 68

Quarterly Cash Flow Statements for Axon Enterprise

This table details how cash moves in and out of Axon Enterprise's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-65 206 -90 211 -68 193 -195 163 129 -231
Net Cash From Operating Activities
41 131 -56 43 63 140 -16 83 91 250
Net Cash From Continuing Operating Activities
41 131 -56 43 63 140 -16 83 91 250
Net Income / (Loss) Continuing Operations
12 29 45 12 61 57 133 41 68 135
Consolidated Net Income / (Loss)
12 29 45 12 61 57 133 41 68 135
Depreciation Expense
6.21 4.95 6.69 7.48 -1.33 6.47 12 13 6.18 18
Non-Cash Adjustments To Reconcile Net Income
43 31 22 98 32 40 -62 73 76 54
Changes in Operating Assets and Liabilities, net
-20 66 -127 -72 -35 37 -95 -41 -65 43
Net Cash From Investing Activities
-103 -529 -73 154 -122 53 -174 82 43 -442
Net Cash From Continuing Investing Activities
-103 -529 -73 154 -122 53 -174 82 43 -442
Purchase of Property, Plant & Equipment
-14 -12 -8.51 -13 -14 -24 -16 -11 -26 -25
Acquisitions
-0.09 0.19 -0.13 -21 0.12 - -238 -0.03 - -384
Purchase of Investments
-95 -574 -145 -112 -188 -119 -251 -240 -124 -178
Sale and/or Maturity of Investments
6.01 57 81 300 80 196 330 334 194 145
Other Investing Activities, net
- - - - - -0.03 - - - 0.02
Net Cash From Financing Activities
-0.07 601 38 14 -7.12 -3.82 -2.71 -2.19 -7.71 -33
Net Cash From Continuing Financing Activities
-0.07 601 38 14 -7.12 -3.82 -2.71 -2.19 -7.71 -33
Other Financing Activities, net
-0.07 -197 38 14 -102 91 -2.71 -2.19 -7.71 -31

Annual Balance Sheets for Axon Enterprise

This table presents Axon Enterprise's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
230 278 338 720 846 1,381 1,688 2,852 3,409 4,475
Total Current Assets
161 177 205 558 609 982 1,109 1,805 2,394 2,297
Cash & Equivalents
60 41 75 349 172 155 356 354 599 455
Short-Term Investments
50 48 6.86 0.00 179 407 87 621 722 532
Note & Lease Receivable
28 39 56 131 147 229 321 358 413 548
Inventories, net
16 35 45 34 39 90 109 202 270 265
Prepaid Expenses
8.17 14 22 30 35 37 57 73 103 130
Other Current Assets
- - 0.00 - 38 64 180 197 287 368
Plant, Property, & Equipment, net
22 24 31 38 44 105 138 170 201 247
Total Noncurrent Assets
47 77 102 123 192 294 440 877 815 1,930
Long-Term Investments
8.53 0.23 - 0.00 45 102 31 156 232 333
Noncurrent Note & Lease Receivables
1.23 18 37 40 32 22 11 5.21 2.59 3.46
Goodwill
9.60 10 15 25 25 25 44 45 58 757
Intangible Assets
7.59 15 19 16 13 9.45 15 12 20 175
Noncurrent Deferred & Refundable Income Taxes
14 20 16 19 28 46 127 157 228 304
Other Noncurrent Operating Assets
5.97 14 15 23 50 88 128 205 275 357
Total Liabilities & Shareholders' Equity
230 278 338 720 846 1,381 1,688 2,852 3,409 4,475
Total Liabilities
73 127 171 252 302 405 640 1,583 1,793 2,147
Total Current Liabilities
38 78 108 166 196 256 419 603 762 998
Accounts Payable
7.33 11 8.59 15 26 24 32 60 66 72
Accrued Expenses
8.64 18 24 41 45 60 104 156 194 279
Customer Deposits
1.23 2.15 - - - 2.96 10 20 22 21
Current Deferred Revenue
21 45 70 107 118 164 266 360 470 613
Other Current Liabilities
0.09 0.08 3.76 2.74 6.83 5.43 6.54 6.36 9.79 13
Total Noncurrent Liabilities
35 49 63 86 107 148 222 981 1,032 1,149
Long-Term Debt
- - - - - - - 674 677 680
Noncurrent Deferred Revenue
30 40 55 - 88 111 186 248 271 361
Noncurrent Deferred & Payable Income Tax Liabilities
1.32 1.90 1.71 2.85 4.19 5.15 4.61 11 18 25
Noncurrent Employee Benefit Liabilities
2.20 3.36 3.86 3.24 3.94 4.73 5.68 6.29 11 16
Other Noncurrent Operating Liabilities
1.03 3.92 2.27 80 11 27 26 42 54 67
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
157 151 167 467 543 976 1,048 1,268 1,616 2,328
Total Preferred & Common Equity
157 151 167 467 543 976 1,048 1,268 1,616 2,328
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
157 151 167 467 543 976 1,048 1,268 1,616 2,328
Common Stock
178 188 202 453 528 962 1,095 1,175 1,347 1,690
Retained Earnings
101 118 123 171 172 170 110 257 435 812
Treasury Stock
-122 -156 -156 -156 -156 -156 -156 -156 -156 -156
Accumulated Other Comprehensive Income / (Loss)
0.08 0.90 -1.47 -1.51 -1.10 0.14 -1.32 -7.18 -11 -18

Quarterly Balance Sheets for Axon Enterprise

This table presents Axon Enterprise's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Total Assets
2,010 2,852 3,008 3,077 3,254 3,409 3,616 3,742 4,006 4,475
Total Current Assets
1,206 1,805 2,053 2,113 2,258 2,394 2,202 2,206 2,434 2,297
Cash & Equivalents
148 354 263 474 406 599 404 566 695 455
Short-Term Investments
230 621 830 660 785 722 660 510 463 532
Note & Lease Receivable
418 358 380 372 443 413 477 386 513 548
Inventories, net
173 202 220 250 260 270 271 278 272 265
Prepaid Expenses
68 73 142 102 104 103 124 122 118 130
Other Current Assets
169 197 217 255 261 287 266 343 373 368
Plant, Property, & Equipment, net
164 170 173 179 187 201 209 215 236 247
Total Noncurrent Assets
641 877 783 786 809 815 1,205 1,321 1,336 1,930
Long-Term Investments
29 156 31 15 0.00 232 295 363 388 333
Noncurrent Note & Lease Receivables
8.46 5.21 4.47 5.28 4.38 2.59 2.40 3.04 2.90 3.46
Goodwill
45 45 45 58 57 58 308 308 308 757
Intangible Assets
13 12 11 22 20 20 89 86 82 175
Noncurrent Deferred & Refundable Income Taxes
96 157 171 199 214 228 209 227 244 304
Other Noncurrent Operating Assets
159 205 223 253 273 275 301 335 311 357
Total Liabilities & Shareholders' Equity
2,010 2,852 3,008 3,077 3,254 3,409 3,616 3,742 4,006 4,475
Total Liabilities
779 1,583 1,605 1,632 1,733 1,793 1,798 1,814 1,906 2,147
Total Current Liabilities
432 603 616 625 718 762 757 766 823 998
Accounts Payable
50 60 66 73 90 66 82 104 76 72
Accrued Expenses
113 156 121 118 147 194 127 142 210 279
Customer Deposits
15 20 14 15 16 22 22 23 22 21
Current Deferred Revenue
246 360 408 412 455 470 516 486 505 613
Other Current Liabilities
6.80 6.36 7.51 7.36 9.49 9.79 9.60 12 11 13
Total Noncurrent Liabilities
348 981 989 1,007 1,015 1,032 1,041 1,047 1,083 1,149
Long-Term Debt
- 674 675 676 676 677 678 679 679 680
Noncurrent Deferred Revenue
314 248 250 265 270 271 294 291 305 361
Noncurrent Deferred & Payable Income Tax Liabilities
7.32 11 16 21 21 18 19 19 20 25
Noncurrent Employee Benefit Liabilities
5.37 6.29 7.98 8.77 9.15 11 15 14 16 16
Other Noncurrent Operating Liabilities
21 42 40 37 38 54 36 44 62 67
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,231 1,268 1,403 1,445 1,521 1,616 1,818 1,929 2,100 2,328
Total Preferred & Common Equity
1,231 1,268 1,403 1,445 1,521 1,616 1,818 1,929 2,100 2,328
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Total Common Equity
1,231 1,268 1,403 1,445 1,521 1,616 1,818 1,929 2,100 2,328
Common Stock
1,167 1,175 1,262 1,293 1,316 1,347 1,421 1,494 1,588 1,690
Retained Earnings
228 257 302 315 374 435 564 605 677 812
Treasury Stock
-156 -156 -156 -156 -156 -156 -156 -156 -156 -156
Accumulated Other Comprehensive Income / (Loss)
-7.81 -7.18 -5.32 -6.73 -13 -11 -12 -14 -9.12 -18

Annual Metrics and Ratios for Axon Enterprise

This table displays calculated financial ratios and metrics derived from Axon Enterprise's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
20.28% 35.55% 28.17% 144.37% -36.81% 28.28% 26.78% 37.50% 31.47% 33.44%
EBITDA Growth
6.61% -8.70% -42.72% 68.33% -84.97% -68.66% -7,222.57% 280.80% -37.57% 192.96%
EBIT Growth
8.71% -9.86% -59.11% 90.75% -125.74% -121.30% -909.60% 234.36% -40.11% 200.05%
NOPAT Growth
-0.60% -12.18% -75.40% 499.99% -110.55% -263.57% -1,088.15% 159.15% 152.18% -67.04%
Net Income Growth
0.08% -13.22% -69.90% 460.88% -96.98% -295.46% -3,381.32% 344.81% 19.64% 114.49%
EPS Growth
-2.70% -11.11% -68.75% 400.00% -98.00% -400.00% -2,933.33% 323.08% 14.78% 106.01%
Operating Cash Flow Growth
31.08% -54.49% -12.60% 245.81% 2.81% -41.41% 223.52% 89.05% -19.59% 115.74%
Free Cash Flow Firm Growth
-24.29% -135.52% 828.21% -247.41% 57.84% -444.33% -69.46% 115.11% -212.03% -1,678.79%
Invested Capital Growth
-0.10% 63.51% -74.77% 638.11% 24.90% 111.87% 57.13% 5.08% 43.81% 128.06%
Revenue Q/Q Growth
4.89% 10.75% 3.80% 110.07% -53.31% 28.33% 19.12% 10.81% 6.38% 7.26%
EBITDA Q/Q Growth
-0.66% 2.01% -5.36% -13.70% -74.10% 107.52% -6.00% 217.94% -13.87% 10.35%
EBIT Q/Q Growth
-1.16% 2.92% -11.94% -18.54% -164.04% 58.76% -5.60% 339.77% -15.99% 12.75%
NOPAT Q/Q Growth
-0.24% 7.34% -61.09% 8.66% -130.20% 58.76% -24.28% 90.21% 18.06% -40.04%
Net Income Q/Q Growth
0.10% 7.70% -61.77% 16.58% -94.25% 95.68% -190.28% 40.66% 18.74% 27.20%
EPS Q/Q Growth
-2.70% 10.34% -61.54% 11.11% -95.65% 95.45% -139.47% 32.68% 18.27% 24.68%
Operating Cash Flow Q/Q Growth
7.74% -44.51% 376.72% 12.14% 28.51% -22.99% -14.66% 100.87% 4.95% 36.93%
Free Cash Flow Firm Q/Q Growth
5.15% -135.79% 193.54% -611.21% -113.40% -39.32% -14.87% 165.97% 39.70% -140.64%
Invested Capital Q/Q Growth
-14.19% 52.15% -85.19% -17.16% -11.49% 16.54% 13.84% -3.71% -3.38% 36.97%
Profitability Metrics
- - - - - - - - - -
Gross Margin
65.01% 63.57% 60.24% 61.56% 57.88% 61.14% 62.65% 61.16% 61.22% 59.61%
EBITDA Margin
20.35% 13.71% 6.13% 4.22% 1.00% 0.25% -13.78% 18.12% 8.60% 18.89%
Operating Margin
17.86% 11.87% 3.79% 2.96% -1.20% -2.08% -19.47% 7.83% 10.05% 2.81%
EBIT Margin
17.86% 11.87% 3.79% 2.96% -1.20% -2.08% -16.55% 16.17% 7.37% 16.56%
Profit (Net Income) Margin
10.07% 6.45% 1.51% 3.48% 0.17% -0.25% -6.95% 12.38% 11.26% 18.10%
Tax Burden Percent
56.37% 54.92% 33.04% 103.92% 42.61% 27.40% 42.45% 74.87% 111.92% 98.83%
Interest Burden Percent
100.07% 98.89% 121.02% 113.14% -32.37% 44.46% 98.96% 102.24% 136.64% 110.61%
Effective Tax Rate
43.63% 45.08% 66.96% -3.92% 57.39% 0.00% 0.00% 25.13% -11.92% 1.17%
Return on Invested Capital (ROIC)
51.45% 34.30% 10.86% 38.58% -2.06% -4.31% -29.35% 13.85% 27.96% 4.76%
ROIC Less NNEP Spread (ROIC-NNEP)
51.43% 34.49% 10.01% 37.15% -3.02% -5.86% -38.79% 2.06% 27.93% -37.41%
Return on Net Nonoperating Assets (RNNOA)
-37.51% -23.07% -7.31% -28.99% 2.23% 4.09% 23.42% -1.17% -15.77% 14.36%
Return on Equity (ROE)
13.93% 11.24% 3.55% 9.58% 0.17% -0.23% -5.93% 12.69% 12.19% 19.12%
Cash Return on Invested Capital (CROIC)
51.54% -13.90% 130.26% -113.70% -24.20% -76.06% -73.78% 8.89% -7.98% -73.31%
Operating Return on Assets (OROA)
17.02% 12.54% 5.82% 5.59% -0.82% -1.27% -9.31% 8.46% 3.67% 8.75%
Return on Assets (ROA)
9.60% 6.81% 2.33% 6.57% 0.11% -0.15% -3.91% 6.47% 5.62% 9.56%
Return on Common Equity (ROCE)
13.93% 11.24% 3.55% 9.58% 0.17% -0.23% -5.93% 12.69% 12.19% 19.12%
Return on Equity Simple (ROE_SIMPLE)
12.70% 11.46% 3.66% 6.25% 0.16% -0.18% -5.73% 11.58% 10.88% 16.20%
Net Operating Profit after Tax (NOPAT)
20 17 4.30 26 -2.72 -9.91 -118 70 176 58
NOPAT Margin
10.07% 6.52% 1.25% 3.07% -0.51% -1.45% -13.63% 5.86% 11.25% 2.78%
Net Nonoperating Expense Percent (NNEP)
0.01% -0.19% 0.85% 1.43% 0.97% 1.54% 9.44% 11.79% 0.03% 42.17%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 3.58% 7.66% 1.92%
Cost of Revenue to Revenue
34.99% 36.57% 39.76% 38.44% 42.12% 38.87% 37.35% 38.84% 38.78% 40.39%
SG&A Expenses to Revenue
35.22% 40.29% 40.34% 18.67% 40.12% 45.12% 59.65% 33.64% 31.71% 35.59%
R&D to Revenue
11.93% 11.41% 16.11% 9.15% 18.97% 18.09% 22.47% 19.70% 19.46% 21.20%
Operating Expenses to Revenue
47.15% 51.70% 56.45% -2.96% 59.09% 63.21% 82.12% 53.33% 51.17% 56.80%
Earnings before Interest and Taxes (EBIT)
35 32 13 25 -6.39 -14 -143 192 115 345
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
40 37 21 35 5.33 1.67 -119 215 134 393
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
5.91 8.40 9.86 5.47 8.00 7.98 10.26 9.31 11.65 18.60
Price to Tangible Book Value (P/TBV)
6.63 10.12 9.86 6.00 8.60 8.27 10.87 9.75 12.24 31.03
Price to Revenue (P/Rev)
4.69 4.72 4.08 3.04 8.19 11.43 12.45 9.95 12.06 20.79
Price to Earnings (P/E)
46.53 73.27 269.29 4.68 4,930.28 0.00 0.00 80.37 107.08 114.85
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.15% 1.36% 0.37% 21.37% 0.02% 0.00% 0.00% 1.24% 0.93% 0.87%
Enterprise Value to Invested Capital (EV/IC)
20.91 18.64 87.81 18.73 26.85 22.84 20.97 22.04 24.23 25.26
Enterprise Value to Revenue (EV/Rev)
4.09 4.40 4.08 2.63 7.44 10.46 11.90 9.56 11.50 20.49
Enterprise Value to EBITDA (EV/EBITDA)
20.09 32.08 66.57 62.26 741.78 4,264.92 0.00 52.78 133.67 108.47
Enterprise Value to EBIT (EV/EBIT)
22.90 37.04 107.67 88.87 0.00 0.00 0.00 59.14 156.13 123.70
Enterprise Value to NOPAT (EV/NOPAT)
40.62 67.44 325.91 85.52 0.00 0.00 0.00 163.07 102.24 737.46
Enterprise Value to Operating Cash Flow (EV/OCF)
17.42 55.82 75.91 34.56 60.18 185.09 82.54 48.23 94.83 104.49
Enterprise Value to Free Cash Flow (EV/FCFF)
40.55 0.00 27.17 0.00 0.00 0.00 0.00 253.99 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.53 0.42 0.29
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.53 0.42 0.29
Financial Leverage
-0.73 -0.67 -0.73 -0.78 -0.74 -0.70 -0.60 -0.57 -0.56 -0.38
Leverage Ratio
1.45 1.65 1.53 1.46 1.55 1.47 1.52 1.96 2.17 2.00
Compound Leverage Factor
1.45 1.63 1.85 1.65 -0.50 0.65 1.50 2.00 2.97 2.21
Debt to Total Capital
0.00% 1.11% 0.00% 0.00% 0.00% 0.00% 0.00% 34.70% 29.53% 22.62%
Short-Term Debt to Total Capital
0.00% 1.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 34.70% 29.53% 22.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 98.89% 100.00% 100.00% 100.00% 100.00% 100.00% 65.30% 70.47% 77.38%
Debt to EBITDA
0.00 0.05 0.00 0.00 0.00 0.00 0.00 3.13 5.04 1.73
Net Debt to EBITDA
0.00 -2.38 0.00 0.00 0.00 0.00 0.00 -2.12 -6.52 -1.62
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.13 5.04 1.73
Debt to NOPAT
0.00 0.10 0.00 0.00 0.00 0.00 0.00 9.68 3.86 11.76
Net Debt to NOPAT
0.00 -5.01 0.00 0.00 0.00 0.00 0.00 -6.56 -4.99 -11.04
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.68 3.86 11.76
Altman Z-Score
10.26 8.34 9.06 8.35 10.11 12.80 10.89 5.75 7.62 13.42
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
4.23 2.27 1.17 3.36 3.12 3.83 2.65 3.00 3.14 2.30
Quick Ratio
3.60 1.65 0.87 2.98 2.54 3.09 1.83 2.21 2.28 1.54
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
20 -7.09 52 -76 -32 -175 -296 45 -50 -891
Operating Cash Flow to CapEx
778.89% 430.01% 177.69% 573.44% 412.03% 53.05% 249.77% 421.78% 317.37% 518.26%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.95 1.06 1.54 1.89 0.68 0.61 0.56 0.52 0.50 0.53
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
4.06 3.88 0.00 0.00 6.16 4.11 3.25 2.96 2.56 3.14
Fixed Asset Turnover
10.05 11.70 0.00 0.00 13.00 9.12 7.08 7.70 8.43 9.30
Accounts Payable Turnover
9.22 10.86 0.00 0.00 10.90 10.58 11.44 10.01 9.62 12.21
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
89.84 94.13 0.00 0.00 59.27 88.81 112.42 123.17 142.42 116.11
Days Payable Outstanding (DPO)
39.57 33.61 0.00 0.00 33.50 34.49 31.90 36.47 37.92 29.90
Cash Conversion Cycle (CCC)
50.26 60.52 0.00 0.00 25.77 54.33 80.52 86.70 104.50 86.21
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
39 63 16 118 147 312 490 515 741 1,689
Invested Capital Turnover
5.11 5.26 8.68 12.56 4.01 2.97 2.15 2.36 2.49 1.71
Increase / (Decrease) in Invested Capital
-0.04 25 -47 102 29 165 178 25 226 948
Enterprise Value (EV)
809 1,180 1,402 2,208 3,952 7,122 10,275 11,352 17,947 42,665
Market Capitalization
927 1,267 1,402 2,557 4,349 7,787 10,749 11,808 18,822 43,303
Book Value per Share
$2.93 $2.89 $2.69 $8.00 $9.16 $15.36 $15.30 $17.82 $21.56 $30.52
Tangible Book Value per Share
$2.61 $2.40 $2.69 $7.30 $8.52 $14.82 $14.44 $17.02 $20.53 $18.30
Total Capital
157 153 142 467 543 976 1,048 1,942 2,293 3,008
Total Debt
0.00 1.69 0.00 0.00 0.00 0.00 0.00 674 677 680
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 674 677 680
Net Debt
-118 -88 0.00 -349 -396 -664 -474 -457 -875 -639
Capital Expenditures (CapEx)
5.96 4.92 10 11 16 73 50 56 60 79
Debt-free, Cash-free Net Working Capital (DFCFNWC)
13 12 17 43 63 164 248 228 312 314
Debt-free Net Working Capital (DFNWC)
123 101 17 392 414 726 691 1,203 1,632 1,300
Net Working Capital (NWC)
123 99 17 392 414 726 691 1,203 1,632 1,300
Net Nonoperating Expense (NNE)
-0.01 0.19 -0.90 -3.39 -3.61 -8.18 -58 -77 -0.24 -319
Net Nonoperating Obligations (NNO)
-118 -88 -126 -349 -396 -664 -558 -753 -875 -639
Total Depreciation and Amortization (D&A)
4.94 4.92 8.04 11 12 16 24 23 19 48
Debt-free, Cash-free Net Working Capital to Revenue
6.82% 4.40% 4.92% 5.08% 11.89% 24.03% 28.72% 19.20% 19.96% 15.06%
Debt-free Net Working Capital to Revenue
62.29% 37.61% 4.92% 46.68% 77.97% 106.55% 80.03% 101.30% 104.58% 62.42%
Net Working Capital to Revenue
62.29% 36.98% 4.92% 46.68% 77.97% 106.55% 80.03% 101.30% 104.58% 62.42%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.37 $0.33 $0.10 $0.52 $0.01 ($0.03) ($0.91) $2.07 $2.35 $4.98
Adjusted Weighted Average Basic Shares Outstanding
53.55M 52.67M 52.73M 56.39M 59.19M 61.78M 66.19M 71.09M 74.20M 75.75M
Adjusted Diluted Earnings per Share
$0.36 $0.32 $0.10 $0.50 $0.01 ($0.03) ($0.91) $2.03 $2.31 $4.80
Adjusted Weighted Average Diluted Shares Outstanding
54.64M 53.54M 53.90M 57.92M 60.02M 61.78M 66.19M 72.53M 75.46M 78.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
53.69M 52.33M 53.03M 58.83M 59.53M 63.78M 70.93M 72.86M 75.30M 76.62M
Normalized Net Operating Profit after Tax (NOPAT)
20 17 9.12 17 -4.48 -9.91 -118 70 110 58
Normalized NOPAT Margin
10.07% 6.52% 2.65% 2.07% -0.84% -1.45% -13.63% 5.86% 7.04% 2.78%
Pre Tax Income Margin
17.87% 11.74% 4.58% 3.35% 0.39% -0.92% -16.37% 16.53% 10.06% 18.32%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
37.91% 195.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Axon Enterprise

This table displays calculated financial ratios and metrics derived from Axon Enterprise's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
34.38% 53.21% 33.78% 31.16% 32.57% 28.93% 34.31% 34.57% 31.70% 33.42%
EBITDA Growth
311.44% 228.45% 54.81% -163.62% 57.96% 82.69% 354.82% 389.84% 24.73% 96.86%
EBIT Growth
1,010.97% 182.25% 87.38% -201.69% 90.83% 94.21% 382.17% 287.43% 11.95% 85.43%
NOPAT Growth
823.06% 198.79% 37.53% 76.75% 162.82% 132.96% -26.88% -5.93% -58.67% -153.53%
Net Income Growth
-75.00% 314.44% -17.74% -75.63% 405.39% 96.49% 195.13% 228.48% 9.32% 138.94%
EPS Growth
-74.63% 454.55% -19.74% -77.46% 376.47% 92.31% 183.61% 231.25% 6.17% 124.00%
Operating Cash Flow Growth
148.65% 914.08% -228.11% 120.15% 53.77% 6.80% 71.70% 94.02% 45.20% 78.64%
Free Cash Flow Firm Growth
46.73% 96.85% -8.17% -25.75% -113.18% -2,834.38% -210.88% -102.52% -144.35% -433.92%
Invested Capital Growth
24.24% 5.08% 34.40% 44.65% 43.33% 43.81% 73.09% 58.37% 60.87% 128.06%
Revenue Q/Q Growth
9.15% 6.93% 2.05% 9.20% 10.32% 3.99% 6.62% 9.41% 7.97% 5.35%
EBITDA Q/Q Growth
36.70% -28.31% 29.86% -149.38% 439.39% -17.09% 230.16% -68.54% 46.06% 30.86%
EBIT Q/Q Growth
49.96% -30.67% 42.93% -167.58% 381.42% -29.44% 262.88% -73.73% 68.08% 16.87%
NOPAT Q/Q Growth
17.12% 0.24% -5.48% 57.45% 74.15% -11.15% -70.21% 102.57% -23.48% -215.06%
Net Income Q/Q Growth
-76.20% 138.78% 54.72% -72.49% 393.63% -7.17% 132.61% -69.38% 64.29% 102.90%
EPS Q/Q Growth
-76.06% 129.41% 56.41% -73.77% 406.25% -7.41% 127.63% -69.36% 62.26% 95.35%
Operating Cash Flow Q/Q Growth
111.09% 220.58% -142.96% 175.73% 47.44% 122.66% -111.38% 619.28% 10.34% 173.94%
Free Cash Flow Firm Q/Q Growth
45.99% 92.76% -2,409.42% -32.82% 8.43% 0.35% -162.36% 13.48% -10.48% -117.74%
Invested Capital Q/Q Growth
4.91% -3.71% 27.51% 12.30% 3.95% -3.38% 54.25% 2.75% 5.59% 36.97%
Profitability Metrics
- - - - - - - - - -
Gross Margin
61.99% 60.94% 59.50% 61.96% 62.10% 61.10% 56.44% 60.25% 60.77% 60.49%
EBITDA Margin
12.17% 8.16% 10.43% -4.72% 14.51% 11.56% 35.31% 10.16% 13.74% 17.06%
Operating Margin
10.30% 6.68% 4.84% 10.75% 13.89% 9.90% 3.53% 6.52% 4.42% -2.56%
EBIT Margin
10.30% 6.68% 9.39% -5.81% 14.83% 10.06% 33.72% 8.10% 12.60% 13.98%
Profit (Net Income) Margin
3.89% 8.69% 13.16% 3.32% 14.83% 13.24% 28.91% 8.09% 12.31% 23.72%
Tax Burden Percent
58.16% 84.08% 107.77% -102.57% 85.47% 102.44% 80.39% 80.64% 84.24% 158.83%
Interest Burden Percent
64.96% 154.76% 130.00% 55.62% 117.07% 128.51% 106.68% 123.97% 116.01% 106.81%
Effective Tax Rate
41.84% 15.92% -7.77% 0.00% 14.53% -2.44% 19.61% 19.36% 15.76% -58.83%
Return on Invested Capital (ROIC)
13.30% 13.26% 11.63% 16.47% 26.77% 25.22% 5.33% 9.99% 7.24% -6.98%
ROIC Less NNEP Spread (ROIC-NNEP)
14.24% 11.70% 7.69% 18.74% 25.09% 23.59% -11.50% 8.05% 1.47% -28.03%
Return on Net Nonoperating Assets (RNNOA)
-8.38% -6.62% -4.21% -9.88% -13.23% -13.32% 5.10% -3.50% -0.66% 10.76%
Return on Equity (ROE)
4.91% 6.64% 7.43% 6.59% 13.55% 11.90% 10.42% 6.49% 6.58% 3.78%
Cash Return on Invested Capital (CROIC)
-14.04% 8.89% -15.95% -15.79% -12.76% -7.98% -37.32% -32.04% -37.02% -73.31%
Operating Return on Assets (OROA)
6.04% 3.49% 5.02% -3.17% 8.26% 5.02% 17.11% 4.30% 6.74% 7.39%
Return on Assets (ROA)
2.28% 4.54% 7.03% 1.81% 8.27% 6.60% 14.68% 4.30% 6.59% 12.53%
Return on Common Equity (ROCE)
4.91% 6.64% 7.43% 6.59% 13.55% 11.90% 10.42% 6.49% 6.58% 3.78%
Return on Equity Simple (ROE_SIMPLE)
8.48% 0.00% 9.79% 6.84% 9.73% 0.00% 14.43% 15.07% 14.12% 0.00%
Net Operating Profit after Tax (NOPAT)
19 19 18 28 49 44 13 27 20 -23
NOPAT Margin
5.99% 5.61% 5.22% 7.52% 11.88% 10.15% 2.84% 5.26% 3.73% -4.07%
Net Nonoperating Expense Percent (NNEP)
-0.95% 1.56% 3.94% -2.27% 1.69% 1.63% 16.83% 1.95% 5.77% 21.05%
Return On Investment Capital (ROIC_SIMPLE)
- 0.96% - - - 1.90% - - - -0.78%
Cost of Revenue to Revenue
38.01% 39.06% 40.50% 38.04% 37.90% 38.90% 43.56% 39.75% 39.23% 39.51%
SG&A Expenses to Revenue
32.73% 33.65% 33.98% 32.01% 29.61% 31.65% 33.14% 33.61% 35.31% 39.58%
R&D to Revenue
18.97% 20.62% 20.68% 19.20% 18.60% 19.54% 19.77% 20.12% 21.03% 23.47%
Operating Expenses to Revenue
51.69% 54.27% 54.66% 51.22% 48.21% 51.19% 52.91% 53.73% 56.34% 63.05%
Earnings before Interest and Taxes (EBIT)
32 22 32 -22 61 43 155 41 69 80
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
38 27 36 -18 60 50 163 51 75 98
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
6.68 9.31 11.68 9.84 9.53 11.65 12.54 11.12 13.87 18.60
Price to Tangible Book Value (P/TBV)
7.01 9.75 12.17 10.41 10.04 12.24 16.05 13.96 17.03 31.03
Price to Revenue (P/Rev)
7.68 9.95 12.83 10.41 9.88 12.06 13.56 11.84 15.00 20.79
Price to Earnings (P/E)
78.76 80.37 119.23 143.80 97.94 107.08 86.91 73.75 98.23 114.85
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.27% 1.24% 0.84% 0.70% 1.02% 0.93% 1.15% 1.36% 1.02% 0.87%
Enterprise Value to Invested Capital (EV/IC)
14.62 22.04 24.26 18.64 18.24 24.23 19.46 17.71 22.91 25.26
Enterprise Value to Revenue (EV/Rev)
7.30 9.56 12.48 10.06 9.53 11.50 13.16 11.42 14.55 20.49
Enterprise Value to EBITDA (EV/EBITDA)
115.63 52.78 140.48 105.69 89.71 133.67 85.35 63.05 79.25 108.47
Enterprise Value to EBIT (EV/EBIT)
179.19 59.14 171.94 123.24 102.21 156.13 93.70 69.25 92.34 123.70
Enterprise Value to NOPAT (EV/NOPAT)
213.71 163.07 207.61 106.41 94.05 102.24 152.20 165.19 292.76 737.46
Enterprise Value to Operating Cash Flow (EV/OCF)
66.75 48.23 117.96 86.79 77.54 94.83 96.30 76.65 94.74 104.49
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 253.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.53 0.48 0.47 0.44 0.42 0.37 0.35 0.32 0.29
Long-Term Debt to Equity
0.00 0.53 0.48 0.47 0.44 0.42 0.37 0.35 0.32 0.29
Financial Leverage
-0.59 -0.57 -0.55 -0.53 -0.53 -0.56 -0.44 -0.44 -0.45 -0.38
Leverage Ratio
1.56 1.96 1.89 1.90 1.91 2.17 2.06 2.02 2.01 2.00
Compound Leverage Factor
1.01 3.03 2.46 1.06 2.24 2.79 2.19 2.51 2.33 2.14
Debt to Total Capital
0.00% 34.70% 32.47% 31.86% 30.78% 29.53% 27.16% 26.03% 24.45% 22.62%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 34.70% 32.47% 31.86% 30.78% 29.53% 27.16% 26.03% 24.45% 22.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 65.30% 67.53% 68.14% 69.22% 70.47% 72.84% 73.97% 75.55% 77.38%
Debt to EBITDA
0.00 3.13 5.95 5.20 4.34 5.04 2.62 2.07 1.91 1.73
Net Debt to EBITDA
0.00 -2.12 -3.97 -3.64 -3.30 -6.52 -2.63 -2.32 -2.43 -1.62
Long-Term Debt to EBITDA
0.00 3.13 5.95 5.20 4.34 5.04 2.62 2.07 1.91 1.73
Debt to NOPAT
0.00 9.68 8.79 5.23 4.55 3.86 4.67 5.42 7.04 11.76
Net Debt to NOPAT
0.00 -6.56 -5.86 -3.67 -3.46 -4.99 -4.69 -6.08 -8.98 -11.04
Long-Term Debt to NOPAT
0.00 9.68 8.79 5.23 4.55 3.86 4.67 5.42 7.04 11.76
Altman Z-Score
7.54 5.55 7.30 6.37 6.26 7.55 8.91 8.30 10.43 13.23
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.79 3.00 3.33 3.38 3.15 3.14 2.91 2.88 2.96 2.30
Quick Ratio
1.84 2.21 2.39 2.41 2.28 2.28 2.03 1.91 2.03 1.54
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-86 -6.20 -150 -199 -183 -182 -467 -404 -446 -972
Operating Cash Flow to CapEx
287.31% 1,131.91% -661.61% 324.78% 450.06% 583.22% -98.63% 731.25% 344.97% 1,008.69%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.59 0.52 0.53 0.55 0.56 0.50 0.51 0.53 0.53 0.53
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
3.10 2.96 2.92 2.63 2.62 2.56 2.72 2.76 2.95 3.14
Fixed Asset Turnover
7.31 7.70 7.92 8.10 8.36 8.43 8.81 9.18 9.18 9.30
Accounts Payable Turnover
10.65 10.01 8.66 7.94 8.11 9.62 9.05 8.22 9.47 12.21
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
117.59 123.17 125.09 139.03 139.05 142.42 133.95 132.31 123.85 116.11
Days Payable Outstanding (DPO)
34.27 36.47 42.14 46.00 45.02 37.92 40.35 44.41 38.53 29.90
Cash Conversion Cycle (CCC)
83.32 86.70 82.96 93.04 94.04 104.50 93.61 87.90 85.32 86.21
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
535 515 657 737 767 741 1,137 1,168 1,233 1,689
Invested Capital Turnover
2.22 2.36 2.23 2.19 2.25 2.49 1.87 1.90 1.94 1.71
Increase / (Decrease) in Invested Capital
104 25 168 228 232 226 480 430 467 948
Enterprise Value (EV)
7,821 11,352 15,933 13,743 13,985 17,947 22,116 20,678 28,249 42,665
Market Capitalization
8,227 11,808 16,383 14,217 14,499 18,822 22,797 21,439 29,116 43,303
Book Value per Share
$17.32 $17.82 $19.26 $19.56 $20.35 $21.56 $24.13 $25.56 $27.79 $30.52
Tangible Book Value per Share
$16.51 $17.02 $18.48 $18.48 $19.31 $20.53 $18.85 $20.35 $22.62 $18.30
Total Capital
1,231 1,942 2,078 2,121 2,197 2,293 2,496 2,608 2,779 3,008
Total Debt
0.00 674 675 676 676 677 678 679 679 680
Total Long-Term Debt
0.00 674 675 676 676 677 678 679 679 680
Net Debt
-406 -457 -450 -474 -514 -875 -681 -761 -867 -639
Capital Expenditures (CapEx)
14 12 8.51 13 14 24 16 11 26 25
Debt-free, Cash-free Net Working Capital (DFCFNWC)
397 228 343 353 349 312 380 363 452 314
Debt-free Net Working Capital (DFNWC)
774 1,203 1,437 1,487 1,540 1,632 1,444 1,440 1,611 1,300
Net Working Capital (NWC)
774 1,203 1,437 1,487 1,540 1,632 1,444 1,440 1,611 1,300
Net Nonoperating Expense (NNE)
6.54 -10 -27 16 -12 -13 -120 -14 -47 -159
Net Nonoperating Obligations (NNO)
-696 -753 -746 -708 -755 -875 -681 -761 -867 -639
Total Depreciation and Amortization (D&A)
5.84 4.95 3.56 4.11 -1.33 6.47 7.36 10 6.18 18
Debt-free, Cash-free Net Working Capital to Revenue
37.01% 19.20% 26.89% 25.88% 23.82% 19.96% 22.63% 20.06% 23.29% 15.06%
Debt-free Net Working Capital to Revenue
72.26% 101.30% 112.54% 108.92% 104.97% 104.58% 85.91% 79.51% 82.95% 62.42%
Net Working Capital to Revenue
72.26% 101.30% 112.54% 108.92% 104.97% 104.58% 85.91% 79.51% 82.95% 62.42%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.17 $0.41 $0.62 $0.17 $0.79 $0.76 $1.77 $0.54 $0.89 $1.78
Adjusted Weighted Average Basic Shares Outstanding
71.11M 71.09M 72.64M 74.22M 74.83M 74.20M 75.36M 75.51M 75.70M 75.75M
Adjusted Diluted Earnings per Share
$0.17 $0.39 $0.61 $0.16 $0.78 $0.75 $1.73 $0.53 $0.86 $1.68
Adjusted Weighted Average Diluted Shares Outstanding
72.53M 72.53M 73.88M 75.78M 75.95M 75.46M 77.13M 77.55M 78.08M 78.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
71.17M 72.86M 73.89M 74.76M 74.93M 75.30M 75.47M 75.57M 76.25M 76.62M
Normalized Net Operating Profit after Tax (NOPAT)
19 19 12 28 49 30 13 27 20 -10
Normalized NOPAT Margin
5.99% 5.61% 3.39% 7.52% 11.88% 6.93% 2.84% 5.26% 3.73% -1.79%
Pre Tax Income Margin
6.69% 10.33% 12.21% -3.23% 17.36% 12.93% 35.97% 10.04% 14.62% 14.93%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Axon Enterprise's Financials

When does Axon Enterprise's financial year end?

According to the most recent income statement we have on file, Axon Enterprise's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Axon Enterprise's net income changed over the last 9 years?

Axon Enterprise's net income appears to be on an upward trend, with a most recent value of $377.03 million in 2024, rising from $19.93 million in 2015. The previous period was $175.78 million in 2023.

What is Axon Enterprise's operating income?
Axon Enterprise's total operating income in 2024 was $58.54 million, based on the following breakdown:
  • Total Gross Profit: $1.24 billion
  • Total Operating Expenses: $1.18 billion
How has Axon Enterprise revenue changed over the last 9 years?

Over the last 9 years, Axon Enterprise's total revenue changed from $197.89 million in 2015 to $2.08 billion in 2024, a change of 952.4%.

How much debt does Axon Enterprise have?

Axon Enterprise's total liabilities were at $2.15 billion at the end of 2024, a 19.7% increase from 2023, and a 2,846.0% increase since 2015.

How much cash does Axon Enterprise have?

In the past 9 years, Axon Enterprise's cash and equivalents has ranged from $40.65 million in 2016 to $598.55 million in 2023, and is currently $454.84 million as of their latest financial filing in 2024.

How has Axon Enterprise's book value per share changed over the last 9 years?

Over the last 9 years, Axon Enterprise's book value per share changed from 2.93 in 2015 to 30.52 in 2024, a change of 942.9%.



This page (LON:AXON) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners